الاتحاد الأوروبي - الرومانية - EMA (European Medicines Agency)

amgen europe b.v. - carfilzomib - mielom multiplu - agenți antineoplazici - kyprolis in combination with daratumumab and dexamethasone, with lenalidomide and dexamethasone, or with dexamethasone alone is indicated for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.

الاتحاد الأوروبي - الرومانية - EMA (European Medicines Agency)

mylan ireland limited - lenalidomidă - mielom multiplu - imunosupresoare - multiple myelomalenalidomide mylan as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide mylan as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone is indicated for the treatment of adult patients with previously untreated multiple myeloma who are not eligible for transplant. lenalidomide mylan in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide mylan in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1-3a).

الاتحاد الأوروبي - الرومانية - EMA (European Medicines Agency)

krka, d.d., novo mesto  - lenalidomide hydrochloride hydrate - multiple myeloma; lymphoma, follicular; myelodysplastic syndromes - imunosupresoare - multiple myelomalenalidomide krka d. as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) este indicat pentru tratamentul pacienților adulți cu mielom multiplu netratați anterior, care nu sunt eligibili pentru transplant. lenalidomide krka d. in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka d. as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. follicular lymphomalenalidomide krka d. in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).

الاتحاد الأوروبي - الرومانية - EMA (European Medicines Agency)

accord healthcare s.l.u. - lenalidomidă - mielom multiplu - imunosupresoare - multiple myelomalenalidomide accord as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide accord as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) este indicat pentru tratamentul pacienților adulți cu mielom multiplu netratați anterior, care nu sunt eligibili pentru transplant. lenalidomida accord în asociere cu dexametazona este indicat pentru tratamentul mielomului multiplu la pacienții adulți care au primit cel puțin un tratament anterior. follicular lymphomalenalidomide accord in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).

الاتحاد الأوروبي - الرومانية - EMA (European Medicines Agency)

theravia - dexametazona - mielom multiplu - corticosteroizi pentru uz sistemic - tratamentul mielomului multiplu.

الاتحاد الأوروبي - الرومانية - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - dexametazona - macular edema; uveitis - ophthalmologicals, other ophthalmologicals - ozurdex este indicat pentru tratamentul pacienților adulți cu edem macular următoarele ramură a retinei-ocluzia venei (brvo) sau centrală a retinei-ocluzia venei (crvo). ozurdex este indicat pentru tratamentul pacienților adulți cu inflamatii ale segmentului posterior al ochiului prezintă ca neinfectioasa uveita. ozurdex este indicat pentru tratamentul pacienților adulți cu deficiente de vedere din cauza edemului macular diabetic (emd) care sunt pseudoafachie sau care sunt considerate suficient de receptiv la, sau improprii pentru non-terapia cu corticosteroizi.

رومانيا - الرومانية - ICBMV (Institutul pentru Controlul Produselor Biologice si Medicamentelor de Uz Veterinar)

norbrook laboratories limited, irlanda de nord - dexametazonă disodium fosfat - soluţie injectabilă - alte medicamente - bovine, cabaline, câini, pisici - cabaline, bovine, caini si pisici antiinflamator.

رومانيا - الرومانية - ICBMV (Institutul pentru Controlul Produselor Biologice si Medicamentelor de Uz Veterinar)

veyx pharma gmbh, germania - dexametazonă, prednisolon acetat - suspensie injectabilă - alte medicamente - bovine, câini, pisici - bovine, câini, pisici În acetonemie, pareza puerperală, tetanie, sindromul vacii culcate,indigestii artrite, tendinite,sinovite,mastite,laminite, toxemie, eclampsie, alergii, anafilaxie, dermatite, eczeme metabolice, prurit, flegmoane, stres, inflamaţii.

رومانيا - الرومانية - ICBMV (Institutul pentru Controlul Produselor Biologice si Medicamentelor de Uz Veterinar)

intervet international bv, Țările de jos - dexametazonă disodium fosfat - soluţie injectabilă - alte medicamente - bovine, cabaline, câini, caprine, pisici, porcine - bovine, porcine, caprine, câini şi pisici: anti-inflamator, anti-alergic, perturbări ale metabolismului energetic şi terapie antişoc. cabaline: anti-inflamator, anti-alergic şi perturbări ale metabolismului energetic. rumegătoare: inducerea parturiţiei

رومانيا - الرومانية - ICBMV (Institutul pentru Controlul Produselor Biologice si Medicamentelor de Uz Veterinar)

pasteur - filiala filipeŞti, românia - dexametazonă disodium fosfat - soluţie injectabilă - alte medicamente - bovine, cabaline, câini, caprine, pisici, porcine - cabaline, bovine, caprine, suine , caini si pisici: indicat in stari de stres,, stari de soc toxic, hemoragic, traumatic, cardiovascular, septic, procese inflamatorii ( miozite,distrofii musculare, colagenoze, boli reumatice, hepatite acute si cronice, dermatite, tenosinovite, bursite), reactii alergice ( eczeme urticarii, conjunctivite, rinite alergice, astm, emfizem alergii alimentare), cetonemie la vaci, inhibarea reactiilor de rejectie a grefelor.